Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Madrenas

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Medicina Clinica|March 7, 1987
[Systemic vasculitis with predominant renal involvement]M Vallés, M Galicia, J Madrenas, et al.
Nephron|January 1, 1986
Digoxin-like immunoreacting activity in the serum of patients on regular hemodialysisJ Madrenas, S Codina, J Monné, et al.
Molecular and Cellular Biology|October 5, 2001
Zap-70-independent Ca(2+) mobilization and Erk activation in Jurkat T cells in response to T-cell antigen receptor ligationX Shan, R Balakir, G Criado, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 1999
The inhibitory function of CTLA-4 does not require its tyrosine phosphorylationM L Baroja, D Luxenberg, T Chau, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 2, 2001
Inhibition of cytokine production and interference in IL-2 receptor-mediated Jak-Stat signaling by the hydroxylamine metabolite of sulfamethoxazoleD A Hess, E F O'Leary, J T Lee, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1988
An alternative approach for statistical analysis of kidney transplant data: multivariate analysis of single-center experienceJ Madrenas, S Newman, J R McGregor, et al.
Clinical and Experimental Immunology|March 8, 2002
Thymic re-entry of mature activated T cells and increased negative selection in vascularized allograft recipientsL A Chau, S Rohekar, J-J Wang, et al.
Immunology|December 14, 1999
CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejectionJ X Gao, J Madrenas, W Zeng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expressionB M Carreno, F Bennett, T A Chau, et al.
Journal of Autoimmunity|March 14, 1998
Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generationA Nabavieh, H Chou, I Volokhov, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Medicina Clinica|March 7, 1987
[Systemic vasculitis with predominant renal involvement]M Vallés, M Galicia, J Madrenas, et al.
Nephron|January 1, 1986
Digoxin-like immunoreacting activity in the serum of patients on regular hemodialysisJ Madrenas, S Codina, J Monné, et al.
Molecular and Cellular Biology|October 5, 2001
Zap-70-independent Ca(2+) mobilization and Erk activation in Jurkat T cells in response to T-cell antigen receptor ligationX Shan, R Balakir, G Criado, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 1999
The inhibitory function of CTLA-4 does not require its tyrosine phosphorylationM L Baroja, D Luxenberg, T Chau, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 2, 2001
Inhibition of cytokine production and interference in IL-2 receptor-mediated Jak-Stat signaling by the hydroxylamine metabolite of sulfamethoxazoleD A Hess, E F O'Leary, J T Lee, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1988
An alternative approach for statistical analysis of kidney transplant data: multivariate analysis of single-center experienceJ Madrenas, S Newman, J R McGregor, et al.
Clinical and Experimental Immunology|March 8, 2002
Thymic re-entry of mature activated T cells and increased negative selection in vascularized allograft recipientsL A Chau, S Rohekar, J-J Wang, et al.
Immunology|December 14, 1999
CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejectionJ X Gao, J Madrenas, W Zeng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expressionB M Carreno, F Bennett, T A Chau, et al.
Journal of Autoimmunity|March 14, 1998
Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generationA Nabavieh, H Chou, I Volokhov, et al.
Pageof 7